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Drugs activating 5-hydroxytryptamine 2C receptors
(5-HT2CRs) potently suppress appetite, but the un-
derlying mechanisms for these effects are not fully
understood. To tackle this issue, we generated
mice with global 5-HT2CR deficiency (2C null) and
mice with 5-HT2CRs re-expression only in pro-opio-
melanocortin (POMC) neurons (2C/POMC mice).
We show that 2C null mice predictably developed
hyperphagia, hyperactivity, and obesity and showed
attenuated responses to anorexigenic 5-HT drugs.
Remarkably, all these deficiencies were normalized
in 2C/POMC mice. These results demonstrate that
5-HT2CR expression solely in POMC neurons is
sufficient to mediate effects of serotoninergic com-
pounds on food intake. The findings also highlight
the physiological relevance of the 5-HT2CR-melano-
cortin circuitry in the long-term regulation of energy
balance.
INTRODUCTION
The central 5-hydroxytryptamine (5-HT) system, including the
5-HT2C receptors (5-HT2CRs) plays critical roles in the regulation
of energy homeostasis. This is best demonstrated by the hyper-
phagia and obesity in mice with global 5-HT2CR deficiency (Non-
ogaki et al., 1998; Tecott et al., 1995). 5-HT2CRs also contribute
to the anorexigenic effects of d-fenfluramine (d-Fen) (Vickers
et al., 1999), a drug that was widely prescribed and was clinically
effective to combat obesity in the 1990s. However, the drug was
withdrawn from clinical use due to adverse cardiopulmonary
events (Connolly et al., 1997). Nonetheless, the efficacy of this
drug regimen in humans underscores the importance of the
central 5-HT system in regulating energy balance and the need
to understand the mechanisms underlying its effects. More
recently, commonly used atypical antipsychotic drugs (AAPDs)
have been reported to cause serious weight gain, which may
be associated with their 5-HT2CR antagonist properties and582 Neuron 60, 582–589, November 26, 2008 ª2008 Elsevier Inc.with polymorphisms in the 5-HT2CR gene (Reynolds et al.,
2002; Templeman et al., 2005). Furthermore, a splicing variant
of 5-HT2CRs with impaired function has been suggested to con-
tribute to hyperphagia and obesity in patients with Prader-Willi
syndrome (Kishore and Stamm, 2006). Collectively, these obser-
vations strongly suggest that an improved understanding of the
mechanisms by which 5-HT2CRs regulate feeding behavior and
body weight homeostasis may not only lead to the development
of antiobesity drugswith fewer side effects but alsomay facilitate
countering the metabolic deficits commonly seen in AAPD
consumers or patients with Prader-Willi syndrome.
Pro-opiomelanocortin (POMC) neurons in the arcuate nucleus
of hypothalamus (ARC) produce a-melanocyte-stimulating hor-
mone (a-MSH), an endogenous agonist of melanocortin 4 recep-
tors (MC4Rs) (Cone, 2005; Elmquist et al., 1999; Williams and
Schwartz, 2005). The central melanocortin system is required
to maintain food intake, body weight, and glucose homeostasis
(Cone, 2005; Elmquist et al., 1999; Williams and Schwartz, 2005;
Yeo et al., 2000).
Themelanocortin pathway hasbeenhypothesized tobedown-
stream of 5-HT2CRs and mediate the effects of 5-HT2CRs on
feeding behavior. Particularly, POMC neurons in the ARC coex-
press 5-HT2CRs (Heisler et al., 2002) and receive inputs from
5-HT-immunoreactive nerve terminals (Kiss et al., 1984). This
anatomical evidence indicates that central 5-HT is positioned to
directly act on POMC neurons via 5-HT2CRs. The potential role
of 5-HT2CRs in POMCneurons is supported by electrophysiolog-
ical studies showing that 5-HT drugs, including d-Fen, activate
POMC neurons via 5-HT2CR-mediated mechanisms (Heisler
et al., 2002; Qiu et al., 2007). In addition, 5-HT2CR agonists stim-
ulate POMC expression in the ARC (Lam et al., 2008; Zhou et al.,
2007). Finally, we have previously shown that the anorexigenic
effect of d-Fen is blunted in mice lacking MC4Rs (Heisler et al.,
2006). Collectively, these findings suggest that the intact central
melanocortin pathway is required for the acute actions of
5-HT2CRs to regulate energy balance. However, whether direct
5-HTaction only onPOMCneurons is sufficient tomediate potent
anorexigenic effects of 5-HTcompounds is unknown. In addition,
the physiological significance of the interaction of the central
melanocortin system and 5-HT2CRs in regulating long-term
energy balance remains to be established.
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global deficiency of 5-HT2CR (2C null) and mice with 5-HT2CRs
re-expressed specifically and only in POMC neurons (2C/
POMC). Taking advantage of these unique genetic models, we
directly tested the hypotheses that 5-HT2CRs in POMC neurons
mediate the anorexigenic effects of 5-HT agents and that the
re-establishment of the 5-HT2CR-melanocortin circuitry is suffi-
cient to rescue the obese phenotypes caused by global
5-HT2CR deficiency.
RESULTS AND DISCUSSION
2C null (loxTB 5-HT2CR) mice were generated by inserting a
loxP-flanked transcription blocker (loxTB) (Balthasar et al.,
2005; Zigman et al., 2005) into the 5-HT2CR gene to globally dis-
rupt its expression. Crossing 2C null mice with POMC-Cre mice
(Balthasar et al., 2004) produced 2C/POMC mice, in which
expression of endogenous 5-HT2CRswas reactivated selectively
in POMC neurons by Cre-recombinase (Figure 1A).
Using PCR primers specific for 5-HT2CRmRNA, we found that
expression of 5-HT2CR mRNA was disrupted in the cerebral
cortex,whole hypothalamus,ARC,andbrainstemof2Cnullmice.
In 2C/POMC mice, 5-HT2CR mRNA was re-expressed only in
samples of the whole hypothalamus or brainstem. Further, we
Figure 1. Generation of loxTB 5-HT2CRMice
(A) A disrupted 5-HT2CR allele was generated by
inserting a loxP-flanked transcriptional blocker
(loxTB) between exons 3 and exon 4 of the
5-HT2CR gene. Expression of Cre-recombinase
removes the transcriptional blocker and allows
5-HT2CR expression.
(B) Messenger RNAs of 5-HT2CR and neuropep-
tide Y (NPY) or POMCwere detected with RT-PCR
in the cerebral cortex, whole hypothalamus, ARC,
brainstem, and pituitary of WT, POMC-Cre, 2C
null, and 2C/POMC mice.
found specific re-expression in samples
ofmicrodissected arcuatenucleus,where
POMC neurons are located (Bronstein
et al., 1992; Elias et al., 1999). We found
no re-expression in the cerebral cortex
(Figure 1B). Thus, 5-HT2CR mRNA was
re-expressed in a POMC-specific man-
ner. Although POMCmRNA is expressed
in the anterior pituitary gland, we found no
endogenous 5-HT2CR mRNA expressed
in the pituitary of wild-type (WT) mice. It
should be noted that POMC is also ex-
pressed by a small population of neurons
in the nucleus of solitary tract (NTS) in the
brainstem (Fan et al., 2004; Huo et al.,
2006), a brain region regulating feeding
and satiety. Thus, in addition to 5-HT2CRs
expressed by ARC POMC neurons, we
cannot rule out that the small number of
POMCneurons in theNTSmay contribute
to the responses outlined below. We were not able to histologi-
cally validate re-expression of 5-HT2CRs specifically in POMC
neurons due to the lack of highly selective reagents such as
5-HT2CR antibodies or ligands specific for 5-HT2CR binding.
To further confirm that our 2C null mice lack 5-HT2CRs, we
assessed the acute effects on food intake to anorexigenic 5-HT
agents in 2C null andWTmice. We found that while d-Fen signif-
icantly reduced 1 hr food intake in WT mice, this acute anorexi-
genic effect was attenuated in 2C null mice (Figure 2A). Similarly,
an agonist of 5-HT2CRs and 5-HT 1B receptors, meta-chlorophe-
nylpiperazine (mCPP) (Hewitt et al., 2002), decreased food intake
inWTmice, an effect that was blunted in 2C null mice (Figure 2B).
These findings are consistent with the results obtained in
conventional 5-HT2CR knockout mice that showed attenuated
anorexigenic effects in response to both d-Fen and mCPP
(Tecott et al., 1995; Vickers et al., 1999).
To determine whether selective re-expression of 5-HT2CRs in
POMC neurons is sufficient to restore the anorexigenic re-
sponses to 5-HT drugs, we assessed 2C/POMC mice, whose
5-HT2CRs were re-expressed selectively in POMC neurons.
Notably, the anorexigenic effects induced by both d-Fen and
mCPP were restored to levels that were indistinguishable from
those in WT mice (Figures 2A and 2B). Thus, in line with our
previous finding that the anorexigenic effect of d-Fen is bluntedNeuron 60, 582–589, November 26, 2008 ª2008 Elsevier Inc. 583
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indicate that 5-HT2CRs expressed by POMC neurons are suffi-
cient to mediate the acute anorexigenic effects of 5-HT
compounds.
5-HT2CRs are also physiological regulators of feeding, as
5-HT2CR knockout mice are hyperphagic (Nonogaki et al.,
1998; Tecott et al., 1995). Consistent with these observations,
our 2C null mice showed a hyperphagic phenotype. Specifically,
a 50% increase in weekly food intake was observed in high fat
diet (HFD)-fed 2C null mice compared to their WT littermates at
11 weeks (Figures 2C). Similarly, 12-week-old chow-fed 2C null
mice were hyperphagic (Figure 2D). Remarkably, food intake of
2C/POMC mice on HFD or chow was comparable to that of WT
mice (Figures 2C and 2D). These findings demonstrate that
5-HT2CRs expressed by POMC neurons are sufficient to normal-
ize the hyperphagia characteristic of mice with 5-HT2CR
deficiency.
Previously, it has been reported that mCPP-induced suppres-
sion in food intake in mice is associated with an early termination
of feeding behavior, an effect that was partially reversed by a se-
lective 5-HT2CR antagonist (Hewitt et al., 2002). Similarly, d-Fen
produces an advanced satiation inWTmice, and this response is
attenuated in mice with 5-HT2CR deficiency (Vickers et al., 1999).
These findings suggest that activation of 5-HT2CRs enhances
Figure 2. 5-HT2CRs in POMC Neurons Res-
cue the Attenuated Anorexigenic Effects of
5-HT Agents, Hyperphagia and Decreased
Satiety in 2C Null Mice
Four-month-old body-weight-matched HFD-fed
mice (n = 6–9 per genotype) were fasted overnight,
and then saline, d-Fen (3 mg/kg) (A), or mCPP
(5 mg/kg) (B) were intraperitoneally injected
30 min prior to presentation of HFD. Food intake
in the following hour was measured and normal-
ized by their body weight. (C) Weekly food intake
was measured in singly housed HFD-fed mice
(n = 5–7 per genotype) at 11 weeks. 2C null mice
consumed significantly more diet than WT, 2C/
POMC, and POMC-Cre mice, and there was no
significant difference in food intake of WT, 2C/
POMC, andPOMC-Cremice. Daily food intake (D),
meal size (E), and meal frequency (F) of 3-month-
old chow-fed mice (n = 5–11 per genotype) were
measured with the TSE system. 2C null mice had
significantly increased food intake and meal size
than WT, and these parameters were not sig-
nificantly different among WT, 2C/POMC, and
POMC-Cre mice. There was no significant differ-
ence inmeal frequency among the four genotypes.
Data are presented as mean ± SEM, and *p < 0.05
and **p < 0.01 in one-way ANOVA analysis with
Student-Newman-Keuls post hoc comparison.
satiety signals to terminate food intake.
Consistent with this notion, here we
show that meal size of 2C null mice was
significantly bigger than that of WT litter-
mates, while their meal frequency was
comparable to that of WT mice (Figures
2E and 2F). However, meal size of 2C/POMC mice was not
statistically different from that of WT mice, which indicates that
5-HT2CRs re-expressed in POMC neurons are sufficient to ad-
vance the satiation process and therefore suppress feeding. In-
terestingly, a proportion of POMC neurons in the ARC have been
shown to project to the NTS in the brainstem to potentiate satiety
signals (Zheng et al., 2005). Thus, it is plausible that endogenous
5-HT, by acting on 5-HT2CRs in the ARC POMC neurons, acti-
vates POMC neurons innervating the NTS to increase satiety
and suppress food intake. However, another possibility that we
cannot exclude is that the 5-HT2CR-induced satiation is, at least
partly, mediated by POMC neurons in the NTS, since 5-HT2CRs
are also reactivated in NTS POMC neurons in 2C/POMC mice.
To test the significance of the 5-HT2CR-melanocortin circuitry
in the long-term regulation of energy homeostasis, we measured
the body weight and body composition of WT, 2C null, and 2C/
POMC mice. Global deletion of 5-HT2CRs leads to late-onset
obesity in chow-fed mice, a phenotype that can be accelerated
by HFD-feeding (Nonogaki et al., 1998). In agreement, we found
that our 2C null mice fedwith HFD showed significant differences
in body weight compared to their WT littermates starting at
14 weeks of age, and by week 26, 2C null mice weighed 8 g
more thanWTmice (Figure 3A). Deletion of 5-HT2CRs also results
in alterations in adiposity. We found a significant increase in fat584 Neuron 60, 582–589, November 26, 2008 ª2008 Elsevier Inc.
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5-HT2CRs in POMC Neurons Regulate Energy BalanceFigure 3. 5-HT2CRs in POMC Neurons Rescue Obesity, Hyperadiposity, and Hyperleptinemia in 2C Null Mice
(A) Weekly body weight wasmeasured in group-housedmice fedwith HFD (n = 20–39 per genotype). Bodyweight of 2C null mice started to be significantly higher
than that of WT, 2C/POMC, and POMC-Cremice from 14 weeks of age, and there was no significant difference in body weight of WT, 2C/POMC, and POMC-Cre
mice. 2C null mice fed with HFD accumulated significantly higher fat mass thanWT, 2C/POMC, and POMC-Cre littermates at week 13 (B) and at week 28 (C), and
lean mass was significantly decreased in young 2C null mice and tended to decrease in old 2C null mice; there was no significant difference in fat mass and lean
mass among WT, 2C/POMC, and POMC-Cremice. N = 6–10 per genotype in (B) and (C). (D) 23-week-old HFD-fed 2C null mice showed significantly increased
visceral and subcutaneous fat storage thanWT, 2C/POMC, and POMC-Cremice, and there was no significant difference in fat distribution inWT, 2C/POMC, and
POMC-Cremice. N = 4–5 per genotype in (D). (E) Eight-month-old HFD-fed 2C null mice had significantly higher leptin level than WT, 2C/POMC, and POMC-Cre
mice, and there was no significant difference in leptin levels of WT, 2C/POMC, and POMC-Cre mice. N = 4–5 per genotype in (E). (F) There is no significant dif-
ference in fed and fasted serum leptin levels in 4-month-old HFD-fed mice (n = 5–6 per genotype). Data are presented as mean ± SEM, and *p < 0.05 and **p <
0.01 in one-way ANOVA analysis with Student-Newman-Keuls post hoc comparison.mass in 2C null mice as early as 13 weeks of age, which was ac-
companied by a decrease in lean mass (Figure 3B). At week 28,
2C null mice accumulated significantly more body fat mass than
WT mice, and their body lean mass tended to decrease (Fig-
ure 3C). We used CT scans to further confirm that 2C null mice
had significantly increased adiposity in both visceral and subcu-
taneous depots (Figure 3D). Notably, we found that selective
re-expression of 5-HT2CRs in POMC neurons was sufficient to
rescue the obese phenotype observed in 2C null mice. Particu-
larly, HFD-fed 2C/POMC mice had comparable body weight as
WT mice (Figure 3A). Both young and old 2C/POMC mice had
similar levels of adiposity as age-matched WT littermates (Fig-
ures 3B and 3C). In addition, visceral and subcutaneous fat
distributions in old 2C/POMC mice were similar to WT mice
(Figure 3D). Thus, these findings demonstrate that 5-HT2CRs
re-expressed in POMC neurons are sufficient to rescue obesity
caused by global 5-HT2CR deficiency.
Secondary to obesity and increased fat mass, mice lacking
5-HT2CRs have been shown to develop late-onset hyperleptine-
mia and leptin insensitivity (Nonogaki et al., 1998). Consistently,
we detected significantly increased serum leptin in old HFD-fed
2C null mice (Figure 3E). Young 2C null mice had similar serum
leptin levels as WT littermates (Figure 3F). Re-expression of
5-HT2CRs in POMC neurons normalized serum leptin level in
old HFD-fed 2C/POMC mice (Figure 3E).It has been reported that young pre-obese 5-HT2CR knockout
mice also display elevated physical activity (Nonogaki et al.,
2003). However, young mutant mice display normal energy
expenditure (Nonogaki et al., 2003). Consistent with these obser-
vations, we found that ambulatory movements and rearing
activities of young chow-fed 2C null mice were significantly
increased compared to WT littermates (Figures 4A and 4B). We
found no difference in the energy expenditure as measured by
O2 consumption and CO2 production (Figures 4C and 4D). Nota-
bly, the hyperactivity of 2C null mice was completely normalized
in 2C/POMC mice (Figures 4A and 4B). These data indicate that
selective re-expression of 5-HT2CRs in POMC neurons is suffi-
cient to normalize the hyperactivity in mice lacking 5-HT2CRs.
In addition to hyperphagia and obesity, another characteristic
phenotype of mice with 5-HT2CR deficiency is spontaneous sei-
zures, which result in a highmortality rate in relatively youngmice
(Tecott et al., 1995). Although we did not quantitatively analyze
the epileptic phenotype in our mice, we anecdotally observed
several episodes of tonic-clonic seizures in both 2C null and
2C/POMC mice. In addition, similar to 5-HT2CR knockout mice
(Tecott et al., 1995), our 2C null mice displayed a significant
decreased survival rate compared to WT mice (see the Supple-
mental Data available online). Interestingly, the survival rate of
HFD-fed 2C null mice is significantly higher than that of 2C null
mice on chow (see Supplemental Data). This is interesting givenNeuron 60, 582–589, November 26, 2008 ª2008 Elsevier Inc. 585
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5-HT2CRs in POMC Neurons Regulate Energy BalanceFigure 4. 5-HT2CRs in POMC Neurons Rescue Hyperactivity in 2C Null Mice
(A) Three-month-old chow-fed 2C null mice showed significantly more ambulatory movement thanWT, 2C/POMC, and POMC-Cremice over the entire 24 hr (left
panel) and 12 hr dark cycle (middle panel), but no significant difference was observed over the 12 hr light cycle (right panel). (B) 2C null mice showed significantly
more rearing activity than WT, 2C/POMC, and POMC-Cremice over the entire 24 hr (left panel), 12 hr dark cycle (middle panel), and 12 hr light cycle (right panel).
There was no significant difference in ambulatorymovement and rearing activity ofWT, 2C/POMC, andPOMC-Cremice. O2 consumption (C) andCO2 production
(D) were not significantly different among four genotypes. N = 5–11 per genotype. Data are presented asmean ± SEM, and **p < 0.01 in one-way ANOVA analysis
with Student-Newman-Keuls post hoc comparison.the fact that epileptic patients can benefit from ketogenic diets
(Kim do and Rho, 2008). Notably, 2C/POMCmice showed a sim-
ilar survival rate to their 2C null littermates, regardless whether
they were fed with HFD or chow (see Supplemental Data). There-
fore, these results suggest that re-expression of 5-HT2CRs in
POMC neurons is not sufficient to rescue the epileptic pheno-
type characteristic of 5-HT2CR knockout mice. One may argue
that the seizures and the associated high mortality rate may
confound the interpretation of the metabolic measurements in
2C null and 2C/POMCmice. However, given the likely metabolic
expense of seizures, we would suggest that the seizure pheno-
type would mask the observed obese phenotype in 5-HT2CR
knockout mice. Finally, it is important to note that 2C null and
2C/POMC mice displayed distinct metabolic profiles despite
the fact that they suffered almost identical mortality rate
(presumably due to similar epileptic status).
Serotoninergic neurons have broad projections that innervate
the entire central nervous system and regulate diverse behaviors
including feeding. For years, research focused on the mecha-
nisms of the central 5-HT system, including 5-HT2CRs, has been
one of the priorities in the obesity field because of the potent586 Neuron 60, 582–589, November 26, 2008 ª2008 Elsevier Inc.effects of serotoninergic agents on feeding. Indeed, drugs gener-
ally influencing 5-HT bioavailability, such as sibutramine, are
among the few approved current pharmacotherapies for obesity.
However, due to the widespread distribution of 5-HT2CRs in the
brain (Molineaux et al., 1989) and the lack of commercially avail-
able 5-HT2CR-selective drugs, discerning mechanisms underly-
ing functions of 5-HT2CRs has proven particularly difficult. Here,
taking advantage of unique genetic mouse models, we have
provided direct evidence that POMC neurons are physiologically
important targets of potent anorexigenic 5-HT compounds such
asd-Fen to suppress food intake. In addition, our results highlight
the importance of the central 5-HT2CRs expressed by POMC
neurons inmaintaining normal feeding behavior and body weight
homeostasis. However, our findings do not demonstrate that
POMCneurons are the only site where 5-HT2CRs regulate energy
balance, asour results donot exclude thepossibility that other re-
dundant neuronal populations expressing 5-HT2CRsmay also be
sufficient to mediate similar effects. For example, in addition to
the ARC, 5-HT2CRs are also found in other brain regions impli-
cated in the regulation of body weight homeostasis, including
the paraventricular nucleus, ventromedial nucleus, dorsomedial
Neuron
5-HT2CRs in POMC Neurons Regulate Energy Balancenucleus, lateral hypothalamic area, and parabrachial nucleus
(Hoffman and Mezey, 1989; Pasqualetti et al., 1999; Wright
et al., 1995). These regions all receive serotoninergic projections
(Petrov et al., 1992; Steinbusch and Nieuwenhuys, 1981). The
physiological relevance of 5-HT2CR expression in these sites is
yet to be characterized. However, our unique mouse model will
allow us to directly address the importance of 5-HT2CRs in any
site in the central nervous system in which specific expression
of Cre-recombinase can be directed.
EXPERIMENTAL PROCEDURES
Generation of 2C Null and 2C/POMC Mice
2C null (LoxTB 5-HT2CR) mice were created by inserting a loxP-flanked tran-
scriptional blocking cassette (loxTB) (Balthasar et al., 2005; Zigman et al.,
2005) between the exons 3 and 4 of the X-linked 5-HT2CR gene (Figure 1A).
The targeting construct was generated using ET cloning and related technolo-
gies within EL250 cells and the BAC that contains the 5-HT2CR gene (Mouse
RPCI.22 BAC clone 32 B 10) (Invitrogen, Carlsbad, CA). The loxTB 5-HT2CR
gene was placed in a pGEM-T plasmid using the following PCR template (left
homology arm [TAATTATAAACACTATTATACACAGAGATTTCCAATTTATTAA
CTAAAATTACTTTCAAAGTCATGCCTTACCGG TCCAACGCGTTGGATGCAT
AG] and right homology arm [GAGCTTAAAACATTAGCAATCAGCAGCAAAGA
TGCA AATATTCCTCAACCGTGTCAGTACTATAGACTAAACCGGTGTATTTT
CTCCTTACGCATC]) and then linearized. The final targeting construct, which
consisted of the 5-HT2CR-loxTB flanked by 4 kb 5-HT2CR homology arms,
was electroporated into ES cells, and correct targeting was confirmed by
Southern blot analyses. For Southern blot analysis, ES cells were digested
with NCO1 for 4 hr at 37C. Primers were labeled withMegaprime DNA labeling
kit. The right probe was 202 bp and amplified using TCACAATTGAAGACA
TTTCCTG and TGTTGGGTTTCTTTGTGGTTCTC. Detection of a nontargeted
ES cell would produce an 11,095 bp band, and a target ES cell would produce
a 6718 bp band. The left probe was 265 bp and amplified using TGTGAGAA
ATGCTGCAGGAATAAA and TTGGGAAGTTTTGTTTTTGTGGA. Detection of
a nontargeted ES cell would produce an 11,095 bp band, while a targeted ES
cell would produce a 6570 bp band. Targeted ES cells were injected into blas-
tocysts, and, after germline transmissionwas established, the chimera carrying
the recombinant allele was crossed onto a C57BL/6J background.
Female loxTB 5-HT2CR heterozygous mice (backcrossed to the C57BL/6J
background for eight generations) were crossedwithmale POMC-Cre hemizy-
gous mice (backcrossed to the C57BL/6J background for five generations),
and only male offspring were collected for the experiments described below.
These male mice carry one of the following genotypes: wild-type (WT), hemi-
zygous loxTB 5-HT2CR (2C null), hemizygous loxTB 5-HT2CR and hemizygous
POMC-Cre (2C/POMC), as well as hemizygous POMC-Cre (POMC-Cre). All
mice were housed in their home cages with food and water available ad libitum
in a temperature-controlled roomwith 12 hr light, 12 hr dark cycle in the animal
facility of University of Texas Southwestern Medical Center at Dallas.
Food Intake and Body Weight
For the HFD-feeding study, mice were group housed (two to five mice per
cage) and providedwith a 42% fat diet (TD.88137, Harlan Teklad) from 5weeks
of age, and body weight was measured weekly. Another HFD cohort was
individually housed, and a similar growth pattern was observed as in the
group-housed cohort. Food intake was measured weekly from mice that
were individually housed.
RT-PCR
The cerebral cortex, whole hypothalamus, ARC, brainstem, and pituitary were
taken from WT, 2C null, 2C/POMC, and POMC-Cre mice. Total RNA was
extracted with the QIAzol Lysis Reagent (QIAGEN, Valencia, CA) and re-
verse-transcribed to cDNA using SuperScript II First-Strand cDNA Synthesis
kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions.
Expression of 5-HT2CR was detected in all the tissues with primers that span
exon 3 and 4 of 5-HT2CR gene (forward, CTCACTCCTTGTGCACCT; reverse,CCCACCAGCATATCAGCAATG). As positive controls, expression of NPY
was detected in the cerebral cortex, whole hypothalamus, and ARC with
NPYprimers (forward, TGCTCGTGTGTTTGGGCATTCTGG; reverse,GAGACA
CTGATTTCAGACCTC); POMC was detected in the brainstem and pituitary
using POMC primers (forward, CAGACCTCCATAGATGTGTGGAGC; reverse,
CTCAGCAACGTTGGGGTACAC). Due to the low level of 5-HT2CR mRNA in
the ARCof 2C/POMCmice, the first PCRproducts of ARC tissues from all mice
were purified and subjected to the second PCR amplification using the same
primers. 5-HT2CR PCR amplicons from the hypothalami of WT, 2C/POMC,
and POMC-Cremice were gel purified and sequenced in the local core facility,
and we confirmed that 5-HT2CRmRNA re-expressed in 2C/POMC hypothala-
mus was identical to those of WT and POMC-Cre hypothalami.
Body Composition and Fat Distribution
Body composition was measured with the Bruker minispec mq10 MRS
system. For fat distribution, mice were anesthetized with 1% isoflurane
inhalation and then the trunk (from base of the skull as the spinal canal begins
to widen and the distal end of the tibia) of each mouse was scanned at an iso-
tropic voxel size of 93 mm (80 kV, 450 mA, and 100 ms integration time) using
the eXplore Locus micro-CT scanner (GE Health Care). Three-dimensional
images were reconstructed from two-dimensional grayscale image slices
and visualized using Microview Software (GEMedical System). Density values
for soft tissue and bone were calibrated from a phantom (GE Health Care)
containing air bubble, water, and hydroxyl apatite rod. The separation of fat
regions was obtained from the appropriate grayscale value (upper threshold,
165; lower threshold, 360). The abdominal muscular wall was used as
the differentiation line to separate visceral adipose tissue from subcutaneous
adipose tissue. The contour lines were drawn around the viscera and three-
dimensional ROI was generated. The visceral fat was determined from the
histogram of these segmented viscera using the same thresholds. Subcutane-
ous fat was obtained by subtracting visceral fat from the total body fat.
Acute Anorexigenic Responses to 5-HT Compounds
To assess whether 5-HT2CRs in POMC neurons are sufficient to mediate
anorexigenic effects of 5-HT compounds, 4-month-old HFD-fed mice were
individually housed and weight matched. After overnight fasting, the mice re-
ceived intraperitoneal injections of saline, d-Fen (3mg/kg), or mCPP (5mg/kg).
HFD was represented to their cages 30 min after the injections. Food intake in
the next hour wasmeasured and normalized by their body weight. Eachmouse
was testedwith all three treatments (d-Fen, mCPP, and saline), administered in
a counterbalanced order, with a minimum of 5 days between the treatments.
Data were presented as mean ± SEM. Differences among genotypes were
determined by two-way ANOVA analysis, followed by the post hoc Student-
Newman-Keuls test.
Serum Leptin
Fed and/or fasted serum leptin levels were measured in HFD-fed mice at 4 or
8 months of age. At month 4, food was removed from the home cages for 2 hr
(fed condition) or for overnight (fasted condition), and bloodwas collected from
the saphenous vein. Atmonth 8, trunk bloodwas collected 2 hr after mice were
deprived of food. Leptin levels were measured using the leptin ELISA kit (Crys-
tal Chem Inc., Downers Grove, IL) according to the manufacturer’s instruction.
Physical Activity, Energy Expenditure, and Meal Patterns
Physical activity, energy expenditure, andmeal patterns were monitored using
a combined indirect calorimetry system (TSE Systems GmbH, Bad Homburg,
Germany) (Pfluger et al., 2008). After adaptation for 6 days, physical activity
was determined for 4 days using amultidimensional infrared light beam system
with beams installed on cage bottom and cage top levels. Ambulatory move-
ment was defined as breaks of any two different light beams at cage bottom
level, while rearing was recorded once the mouse broke any light beam at
the top level. Simultaneously, O2 consumption and CO2 production were mea-
sured to determine the energy expenditure. In addition, meal patterns were
determined continuously by integration of weighing sensors fixed at the top
of the cage from which the food containers have been suspended into the
sealed cage environment. Meals were defined as food intake events with a
minimum duration of 60 s and a break of 300 s between food intake events.Neuron 60, 582–589, November 26, 2008 ª2008 Elsevier Inc. 587
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Datawere presented asmean ±SEM. Statistical analyseswere carried out with
SigmaStat software. Unless otherwise mentioned, all data were analyzed by
one-way ANOVA analysis, followed by the post hoc Student-Newman-Keuls
test when the ANOVA analysis indicated significant differences. p < 0.05
indicated statistical significance.
SUPPLEMENTAL DATA
The Supplemental Data include one figure and can be found with this article
online at http://www.neuron.org/supplemental/S0896-6273(08)00801-5.
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